Navigation Links
Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
Date:5/6/2008

Tuesday, May 13, 2008 10:00 a.m. EDT http://www.westaim.com

CALGARY, May 6 /PRNewswire-FirstCall/ - The Westaim Corporation will hold a webcast at 10:00 a.m. EDT on Tuesday, May 13, 2008 to broadcast the Company's Annual Meeting of Shareholders.

The Westaim Corporation will be releasing its 2008 first quarter results on Monday, May 12, 2008 after market close. In addition to standard disclosure over wire services, a news release and financial statements will be posted on the Westaim web site.

To listen to the Annual Meeting of Shareholders webcast live on the Internet, please go to http://www.westaim.com.

Ian W. Delaney, Chairman of the Board, The Westaim Corporation and Drew Fitch, President & Chief Executive Officer, The Westaim Corporation will participate on the webcast.

An audio file of the webcast will be archived and posted on the Westaim web site.

The Westaim Corporation's investments include iFire Technology Ltd., and a 74.5 per cent interest in NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS). Westaim's common shares are listed and on The Toronto Stock Exchange under the trading symbol WED.


'/>"/>
SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Mettler-Toledo International Inc. Announces Webcast of Presentation at Bank of America Healthcare Conference
2. AMERIGROUP Corporation to Webcast Annual Meeting of Stockholders on May 8, 2008
3. Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008
4. Novadaq to hold first quarter 2008 results conference call and webcast
5. CryoCath to Hold Second Quarter 2008 Conference Call and Webcast
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
7. West Pharmaceutical Services, Inc. Announces Annual Meeting Webcast
8. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
9. Webcast Alert: Neurocrine Announces 1Q08 Financial Results
10. Webcast Alert: HCA announces HCA 1Q 2008 Earnings Report
11. NBTY to Webcast Presentation at Lehman Brothers 11th Annual Retail and Restaurant Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... The American Academy of...an 75,000 clinically practicing physician assistan... the U.S. House of Representatives for passing Sat...Affordable Health Care for America Act. ,, "We ...l ultimately lower the cost of health care and gre...
(Date:11/9/2009)...use funds to move lab findings into human therapy ...n from nerve damage ,, ANN ARBOR, Mich., Nov. ...niversity of Michigan Department of Neurology have...therapy for neuropathic pain, a difficult-to-treat...se of damage to nerve without obvious tissue injur...
(Date:11/9/2009)...ble in French . , , Montreal, November 9, 20...emale. In human bodies trillions of cells are coup... are composed. Yet these don,t come in twos, they...cause these complex cell networks are the backbone...ed for ways to splice cell clusters down to their ...
(Date:11/9/2009)...9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the ...announced the availability of INTUNIV (guanfacine)... United States for the treatment of Attention-Defi...adolescents ages 6 to 17. INTUNIV, a once-daily f...nscheduled alpha-2A receptor agonist approved for ...
(Date:11/9/2009)...eople around the world suffer from cataracts. Thom...d his coauthors discuss cataract surgery with the ...issue of Deutsches rzteblatt International ( Dts...lindness is usually due to opacification of the le...perations are performed each year. Cataracts can b...
Breaking Medicine News(10 mins):Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4
...arry Minnix, President & CEO, American Association...ation of the Medicare Therapy,Caps Exceptions Proc...,from Larry Minnix, President & CEO, American Asso...in having their physical and,occupational therapy ...
... The American Medical,Association (AMA) Foundation...ysician association, recently named several new bo...ers:, -- Jean Howard, Traverse City, MI, Preside...aynard, M.D., Evansville, IN, Secretary, New Mem...
...l sunscreen available at retailers nationwide and ... , ORLANDO, Fla., July 2 Caribbean Solutions,( h...een, Caribbean Sol,SolGuard SPF 25 and Kids Kare 2...ttp://www.newscom.com/cgi-bin/prnh/20080702/LAW520...
... only to childbirth as most common reason for hosp..., July 2 (HealthDay News) -- In 2006, more than 1....opulation of Dallas -- were hospitalized for pneum...mission to hospital, and treating these lung infec...
...Technologies from Los Alamos National Laboratory ... Airplanes, Cars Go On a Nanotechnology ...fics (Pink Sheets: MHTX) announced today that it h...enator,Jeff Bingaman said, "I believe the merger o...
...(July 2, 2008) - Measuring calcium deposits in the...isk in American adults, even when they are elderly...ssue of Journal of the American College of Cardio...l Center (LA BioMed), said previous studies had fo...
Other Medicine News:Health News:AAHSA Statement: Therapy Caps Ration Care 2Health News:Caribbean Sol Biodegradable Sunscreen Gets Strong Safety Rating From Environmental Working Group 2Health News:Manhattan Scientifics Acquires Metallicum, Inc. 2Health News:Manhattan Scientifics Acquires Metallicum, Inc. 3Health News:Manhattan Scientifics Acquires Metallicum, Inc. 4Health News:New study finds coronary arterial calcium scans help detect overall death risk in the elderly 2
(Date:11/9/2009)..., MIAMI, Nov. 9 ISTA P...nced additional results from the Company,s Bepreve...5% Phase 3 clinical studies. These results were p...ting of the American College of Allergy, Asthma &a...In a poster presentation titled, "Treatment of Ocu...
(Date:11/9/2009)..., SUNNYVALE, Calif., Nov. 9 /PRNewswire-FirstCal...harmaceutical company focused on developing and co...the treatment of immune mediated diseases and canc...sident, Preclinical Development will provide an ov... Merriman Curhan Ford,s 6th Annual Investor Summit...
(Date:11/9/2009)..., SOUTH SAN FRANCISCO, Calif., Nov. 9 /PRNewswir...ay announced that on November 5, 2009, it received...q") stating that the Nasdaq Hearing Panel has gran... NASDAQ Global Market subject to the condition tha...er 31, 2009, the proposed merger (the "Merger") co...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3David Yap receives Amethyst Award 51065 1LocumTenens com Expands Service Lines to Include Primary Care 51062 1LocumTenens com Expands Service Lines to Include Primary Care 51062 2LocumTenens com Expands Service Lines to Include Primary Care 51062 3Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 1Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 2Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 3Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 4
...3 Telik, Inc.,(Nasdaq: TELK ) announced it will ... of TELINTRA(R) (ezatiostat HCl) Tablets at the 49...ology. The presentation is,scheduled for Saturday,...,and B4 at the Georgia World Congress Center in At...608) is titled: "Phase 1 Dose Escalation Study of,...
...ance to Phase III Clinical Trial, PALO ALTO, Cali...d: AVGO), a late-stage biotechnology company that,...eurodegenerative,diseases, today announced positiv...AL-08, the Company,s second generation proprietary...ose of the trial was to determine which,of two com...
Other Medicine Technology:Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 2Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 3Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 4
Steroid 21-Hydroxylase (21-OH) Autoantibody RIA
...ELISA test kit is intended for the quantitative de...This exceptionally sensitive ELISA procedure offer...y), providing for accurate establishment of post-a...ventional methods. Furthermore, with the ability t...
...r use with 4, 8, or 12 channel pipettors. Angled s...rly all of the solution. Corners have pouring lips...rgin polystyrene containing no regrinds. Sterile 5...y irradiation. Dimensions: 78 mm W x 152 mm L x 35...
Sterile Individually Packed 100 mL Solution Basins
Medicine Products: